[1] Palatinus JA, Das S. Your father and grandfather's atrial fibrillation: a review of the genetics of the most common pathologic cardiac dysrhythmia[J]. Curr Genomics, 2015, 16(2): 75-81.
[2] 谭红伟, 邱建平, 刘学波. 心房颤动导管消融围手术期抗凝治疗策略[J]. 国际心血管病杂志, 2015, 42(3): 147-150.
[3] 王 骏, 张代富. 心房颤动相关4q25基因座单核苷酸多态性的研究进展[J]. 国际心血管病杂志, 2014, 41(3): 143-145.
[4] Holm H, Gudbjartsson DF, Arnar DO, et al. Several common variants modulate heart rate, PR interval and QRS duration[J]. Nat Genet, 2010, 42(2): 117-122.
[5] Zang X, Zhang S, Xia Y, et al. SNP rs3825214 in TBX5 is associated with lone atrial fibrillation in Chinese Han population[J]. PLoS One, 2013, 8(5): e64966.
[6] Sinner MF, Tucker NR, Lunetta KL, et al. Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation[J]. Circulation, 2014, 130(15): 1225-1235.
[7] Postma AV, van de Meerakker JB, Mathijssen IB, et al. A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation[J]. Circ Res, 2008, 102(11): 1433-1442.
[8] January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J]. Circulation, 2014, 130(23): e199-e267.
[9] Zhang XL, Qiu XB, Yuan F, et al. TBX5 loss-of-function mutation contributes to familial dilated cardiomyopathy[J]. Biochem Biophys Res Commun, 2015, 459(1): 166-171.
[10] Zhou W, Zhao L, Jiang JQ, et al. A novel TBX5 loss-of-function mutation associated with sporadic dilated cardiomyopathy[J]. Int J Mol Med, 2015, 36(1): 282-288.
[11] Greulich F, Rudat C, Kispert A. Mechanisms of T-box gene function in the developing heart[J]. Cardiovasc Res, 2011, 91(2): 212-222.
[12] Mahida S. Transcription factors and atrial fibrillation[J]. Cardiovasc Res, 2014, 101(2): 194-202.
[13] Mommersteeg MT, Christoffels VM, Anderson RH, et al. Atrial fibrillation: a developmental point of view[J]. Heart Rhythm, 2009, 6(12): 1818-1824.
[14] Bruneau BG, Nemer G, Schmitt JP, et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease[J]. Cell, 2001, 106(6): 709-721.
[15] Hatcher CJ, Goldstein MM, Mah CS, et al. Identification and localization of TBX5 transcription factor during human cardiac morphogenesis[J]. Dev Dyn, 2000, 219(1): 90-95.
[16] Al-Qattan MM, Abou Al-Shaar H. Molecular basis of the clinical features of Holt-Oram syndrome resulting from missense and extended protein mutations of the TBX5 gene as well as TBX5 intragenic duplications[J]. Gene, 2015, 560(2): 129-136.
[17] Baruteau AE, Probst V, Abriel H. Inherited progressive cardiac conduction disorders[J]. Curr Opin Cardiol, 2015, 30(1): 33-39.